Aiken Chris B, Weisler Richard H, Sachs Gary S
Mood Treatment Center, 1615 Polo Road, Winston-Salem, NC 27106, USA; Wake Forest University School of Medicine, Winston-Salem, NC, USA.
University of North Carolina at Chapel Hill, NC, USA; Duke University Medical Center, Durham, NC, USA.
J Affect Disord. 2015 May 15;177:59-64. doi: 10.1016/j.jad.2015.02.004. Epub 2015 Feb 12.
The Bipolarity Index is a clinician-rated scale that rates cardinal features of the disorder across five domains: signs and symptoms, age of onset, course of illness, response to treatment, and family history. We tested the Index in routine clinical practice to identify the optimal cut-off for distinguishing bipolar from non-bipolar disorders.
Sequential patients in a private practice were rated with the Bipolarity Index (n=1903) at intake. Diagnoses were made with the MINI-6.0.0 International Neuropsychiatric Interview according to DSM-IV-TR criteria, except that cases of antidepressant-induced mania and hypomania were included in the bipolar group. A subset completed the self-rated Mood Disorder Questionnaire (MDQ) (n=1620) or Bipolar Spectrum Diagnostic Scale (BSDS) (n=1179). The primary analysis compared Bipolarity Index scores for bipolar vs. non-bipolar patients using receiver operator curves (ROC) to determine the optimal cut-off score. Secondary outcomes repeated this analysis with the MDQ, MDQ-7 (using only the symptomatic items of the MDQ) and BSDS.
At a cut-off of ≥50, the Bipolarity Index had a high sensitivity (0.91) and specificity (0.90). Optimal cut-offs for self-rated scales were: MDQ: ≥7 (sensitivity 0.74, specificity 0.71); MDQ-7: ≥6 (sensitivity 0.77, specificity 0.77); BSDS: ≥12 (sensitivity 0.71, specificity 0.77).
The study utilized one rater at a single practice site; the rater was not blinded to the results of the MINI.
The Bipolarity Index can enhance the clinical assessment of mood disorders and, at a score ≥50 has good sensitivity and specificity for identifying bipolar disorders.
双相性指数是一种由临床医生评定的量表,用于对该疾病的主要特征在五个领域进行评分:体征和症状、发病年龄、病程、对治疗的反应以及家族史。我们在常规临床实践中对该指数进行了测试,以确定区分双相情感障碍和非双相情感障碍的最佳临界值。
在一家私人诊所,对连续就诊的患者在初诊时使用双相性指数进行评分(n = 1903)。根据DSM-IV-TR标准,采用MINI-6.0.0国际神经精神访谈进行诊断,但双相情感障碍组包括抗抑郁药诱发的躁狂和轻躁狂病例。一部分患者完成了自评的心境障碍问卷(MDQ)(n = 1620)或双相谱诊断量表(BSDS)(n = 1179)。主要分析使用受试者工作特征曲线(ROC)比较双相情感障碍患者和非双相情感障碍患者的双相性指数得分,以确定最佳临界值。次要结果使用MDQ、MDQ-7(仅使用MDQ的症状项目)和BSDS重复此分析。
临界值≥50时,双相性指数具有较高的敏感性(0.91)和特异性(0.90)。自评量表的最佳临界值为:MDQ:≥7(敏感性0.74,特异性0.71);MDQ-7:≥6(敏感性0.77,特异性0.77);BSDS:≥12(敏感性0.71,特异性0.77)。
该研究在单一诊所地点由一名评定者进行;评定者知晓MINI的结果。
双相性指数可增强心境障碍的临床评估,得分≥50时对识别双相情感障碍具有良好的敏感性和特异性。